DeBay DR - Search Results

1

Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.

Macdonald IR, Maxwell SP, Reid GA, Cash MK, DeBay DR, Darvesh S. Macdonald IR, et al. Among authors: debay dr. J Alzheimers Dis. 2017;58(2):491-505. doi: 10.3233/JAD-170164. J Alzheimers Dis. 2017. PMID: 28453492 Free PMC article.

2

Early detection of cerebral glucose uptake changes in the 5XFAD mouse.

Macdonald IR, DeBay DR, Reid GA, O'Leary TP, Jollymore CT, Mawko G, Burrell S, Martin E, Bowen CV, Brown RE, Darvesh S. Macdonald IR, et al. Among authors: debay dr. Curr Alzheimer Res. 2014;11(5):450-60. doi: 10.2174/1567205011666140505111354. Curr Alzheimer Res. 2014. PMID: 24801216 Free PMC article.

3

Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves ¹⁸FDG retention in 5XFAD mouse model of Alzheimer's disease.

DeBay DR, Reid GA, Macdonald IR, Mawko G, Burrell S, Martin E, Bowen CV, Darvesh S. DeBay DR, et al. Brain Res. 2017 Sep 15;1671:102-110. doi: 10.1016/j.brainres.2017.07.009. Epub 2017 Jul 17. Brain Res. 2017. PMID: 28729192

4

Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease.

DeBay DR, Reid GA, Pottie IR, Martin E, Bowen CV, Darvesh S. DeBay DR, et al. Alzheimers Dement (N Y). 2017 Feb 24;3(2):166-176. doi: 10.1016/j.trci.2017.01.005. eCollection 2017 Jun. Alzheimers Dement (N Y). 2017. PMID: 29067326 Free PMC article.

5

No difference in cerebral perfusion between the wild-type and the 5XFAD mouse model of Alzheimer's disease.

DeBay DR, Phi TT, Bowen CV, Burrell SC, Darvesh S. DeBay DR, et al. Sci Rep. 2022 Dec 22;12(1):22174. doi: 10.1038/s41598-022-26713-x. Sci Rep. 2022. PMID: 36550188 Free PMC article.

6

Using lymph node swelling as a potential biomarker for successful vaccination.

Brewer KD, DeBay DR, Dude I, Davis C, Lake K, Parsons C, Rajagopalan R, Weir G, Stanford MM, Mansour M, Bowen CV. Brewer KD, et al. Among authors: debay dr. Oncotarget. 2016 Jun 14;7(24):35655-35669. doi: 10.18632/oncotarget.9580. Oncotarget. 2016. PMID: 27232944 Free PMC article.

7

Using MRI to evaluate and predict therapeutic success from depot-based cancer vaccines.

DeBay DR, Brewer KD, LeBlanc SA, Weir GM, Stanford MM, Mansour M, Bowen CV. DeBay DR, et al. Mol Ther Methods Clin Dev. 2015 Dec 16;2:15048. doi: 10.1038/mtm.2015.48. eCollection 2015. Mol Ther Methods Clin Dev. 2015. PMID: 26730395 Free PMC article.

8

In vivo detection of human TRPV6-rich tumors with anti-cancer peptides derived from soricidin.

Bowen CV, DeBay D, Ewart HS, Gallant P, Gormley S, Ilenchuk TT, Iqbal U, Lutes T, Martina M, Mealing G, Merkley N, Sperker S, Moreno MJ, Rice C, Syvitski RT, Stewart JM. Bowen CV, et al. PLoS One. 2013;8(3):e58866. doi: 10.1371/journal.pone.0058866. Epub 2013 Mar 15. PLoS One. 2013. PMID: 23554944 Free PMC article.

9

Impact of hepatocyte growth factor on skeletal myoblast transplantation late after myocardial infarction.

O'Blenes SB, Li AW, Bowen C, Debay D, Althobaiti M, Clarke J. O'Blenes SB, et al. Drug Target Insights. 2013 May 6;7:9-17. doi: 10.4137/DTI.S11802. Print 2013. Drug Target Insights. 2013. PMID: 23700363 Free PMC article.

10

Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRI.

Brewer KD, Lake K, Pelot N, Stanford MM, DeBay DR, Penwell A, Weir GM, Karkada M, Mansour M, Bowen CV. Brewer KD, et al. Among authors: debay dr. Vaccine. 2014 Dec 5;32(51):6956-6962. doi: 10.1016/j.vaccine.2014.10.058. Epub 2014 Nov 4. Vaccine. 2014. PMID: 25444822

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page